Chloe provides strategic counsel and communications support to companies involved in a broad range of special situations and highly nuanced matters, including mergers and acquisitions, shareholder activism defense, leadership changes, litigation, and crisis management. She also works with clients to develop and refine their investor relations and stewardship engagement programs with a focus on corporate governance and executive compensation. Select experience includes:

Mergers & Acquisitions

Chloe has supported Bristol Myers Squibb in its acquisitions of Celgene and MyoKardia; Broadcom in its acquisition of VMware; Red Hat in its sale to IBM; Kansas City Southern in its acquisition by Canadian Pacific and unsolicited offer from Canadian National; Prologis in its unsolicited takeover approach and subsequent acquisition of Duke Realty; ONEOK in its acquisition of Magellan Midstream Partners; Healthcare Trust of America in its sale to Healthcare Realty; Centene in its acquisition of WellCare; First Horizon and IBERIABANK in their merger of equals; Merck in its acquisition of Acceleron; Choice Hotels in its takeover proposal for Wyndham Hotels & Resorts; Terminix Global Holdings in its sale to Rentokil Initial; Thermo Fisher Scientific in its acquisition of The Binding Site Group; US Ecology in its sale to Republic Services; Avon Products in its sale to Natura &Co; and The Simply Good Foods Company in its acquisition of Quest Nutrition.

Shareholder Activism Defense

She has also supported Verisk Analytics in its settlement agreement with D.E. Shaw; American Campus Communities in its successful defense against Land & Buildings; The New York Times Company in its engagement with ValueAct; PDC Energy in its successful proxy contest against Kimmeridge; Eagle Materials in its settlement agreement with Sachem Head, Southwest Gas Holdings in its settlement agreement with Carl Icahn, Huntsman Corporation in its successful proxy contest against Starboard; GCP Applied Technologies in its proxy contest against Starboard; and Delek US Holdings in its successful proxy contest against CVR Energy and Carl Icahn.

Crisis Management

Chloe advises on sensitive and highly nuanced matters, including leadership changes, litigation, regulatory inquiries, and financial and operational events, among other crises.

Chloe joined Joele Frank in 2018. She earned a B.A. from the University of Pennsylvania. She is on the Board of Directors of the Phi Beta Kappa Association of New York.